Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. - Archive ouverte HAL Access content directly
Journal Articles Journal of the American Society of Nephrology Year : 2007

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

(1) , (2) , (2) , (1) , (3) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (1)
1
2
3
4
5
6
7
8
9
10
11
12

Abstract

Mutations in factor H (CFH), factor I (IF), and membrane cofactor protein (MCP) genes have been described as risk factors for atypical hemolytic uremic syndrome (aHUS). This study analyzed the impact of complement mutations on the outcome of 46 children with aHUS. A total of 52% of patients had mutations in one or two of known susceptibility factors (22, 13, and 15% of patients with CFH, IF, or MCP mutations, respectively; 2% with CFH+IF mutations). Age <3 mo at onset seems to be characteristic of CFH and IF mutation-associated aHUS. The most severe prognosis was in the CFH mutation group, 60% of whom reached ESRD or died within <1 yr. Only 30% of CFH mutations were localized in SCR20. MCP mutation-associated HUS has a relapsing course, but none of the children reached ESRD at 1 yr. Half of patients with IF mutation had a rapid evolution to ESRD, and half recovered. Plasmatherapy seemed to have a beneficial effect in one third of patients from all groups except for the MCP mutation group. Only eight (33%) of 24 kidney transplantations that were performed in 15 patients were successful. Graft failures were due to early graft thrombosis (50%) or HUS recurrence. In conclusion, outcome of HUS in patients with CFH mutation is catastrophic, and posttransplantation outcome is poor in all groups except for the MCP mutation group. New therapies are urgently needed, and further research should elucidate the unexplained HUS group.

Dates and versions

inserm-00409786 , version 1 (12-08-2009)

Identifiers

Cite

Anne-Laure Sellier-Leclerc, Veronique Fremeaux-Bacchi, Marie-Agnès Dragon-Durey, Marie-Alice Macher, Patrick Niaudet, et al.. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.. Journal of the American Society of Nephrology, 2007, 18 (8), pp.2392-400. ⟨10.1681/ASN.2006080811⟩. ⟨inserm-00409786⟩
331 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More